dc.contributor.author | ŞENOCAK, Mustafa Şükrü | |
dc.date.accessioned | 2021-03-05T09:37:40Z | |
dc.date.available | 2021-03-05T09:37:40Z | |
dc.date.issued | 2008 | |
dc.identifier.citation | ŞENOCAK M. Ş. , "Assessing the quality of randomized controlled trials from two leading cancer journals using the CONSORT statement", Hematology Oncoloy Stem Cell Thearapy, ss.38-43, 2008 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_9ebcdd5b-b0cd-4a87-9c70-d84f88586065 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/106595 | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.title | Assessing the quality of randomized controlled trials from two leading cancer journals using the CONSORT statement | |
dc.type | Makale | |
dc.relation.journal | Hematology Oncoloy Stem Cell Thearapy | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.issue | 1 | |
dc.identifier.startpage | 38 | |
dc.identifier.endpage | 43 | |
dc.contributor.firstauthorID | 313072 | |